L Donner
Impact in
- Neurology top 10%
- Neurological Disorders and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroblastoma Research and Treatments
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
- Hematology 10
- Platelet Disorders and Treatments 7
- Blood groups and transfusion 2
-
- Alzheimer's disease research and treatments 8
- Co-authors
- Margitta Elvers (11 shared papers)Martin Schaller (4 shared papers)Nina Sarah Gowert (4 shared papers)Oliver Borst (2 shared papers)Florian Läng (2 shared papers)Patrick Münzer (2 shared papers)Dieter Willbold (3 shared papers)Lothar Gremer (3 shared papers)
In The Last Decade
L Donner
31 papers receiving 561 citations
Peers
Comparison fields: 5 of 79
- Neurology 120
- Clinical Biochemistry 69
- Hematology 105
- Physiology 196
- Neurology 98
Countries citing papers authored by L Donner
This map shows the geographic impact of L Donner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Donner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Donner more than expected).
Fields of papers citing papers by L Donner
This network shows the impact of papers produced by L Donner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Donner. The network helps show where L Donner may publish in the future.
Co-authors
The 25 scholars most cited alongside L Donner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 115 | |
| 2 | 2016 | 92 | |
| 3 | Biological classification of cell lines derived from human extra-cranial neural tumors. | 1988 | 80 |
| 4 | 2014 | 65 | |
| 5 | 2023 | 31 | |
| 6 | 2021 | 23 | |
| 7 | 2017 | 22 | |
| 8 | 2020 | 20 | |
| 9 | 2018 | 17 | |
| 10 | 2017 | 17 | |
| 11 | 1961 | 15 | |
| 12 | 1977 | 11 | |
| 13 | 1974 | 11 | |
| 14 | 1962 | 8 | |
| 15 | Daunorubicin and adriamycin in the treatment of leukemia. | 1973 | 7 |
| 16 | 1967 | 5 | |
| 17 | 1977 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2017 | 4 | |
| 20 | [The effect of dicumarol preparations on fibrinolysis]. | 1960 | 4 |
About L Donner
L Donner is a scholar working on Hematology, Physiology, Pulmonary and Respiratory Medicine, Genetics and Oncology, having authored 38 papers that have together received 579 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (8 papers), Platelet Disorders and Treatments (7 papers), Cancer Treatment and Pharmacology (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Advanced Glycation End Products research (3 papers), Blood groups and transfusion (2 papers) and Kruppel-like factors research (2 papers). The work is most often cited by research in Neurology (120 citations), Clinical Biochemistry (69 citations), Hematology (105 citations), Physiology (196 citations) and Neurology (98 citations). L Donner has collaborated with scholars based in Germany, Czechia and Sweden. Frequent co-authors include Margitta Elvers, Martin Schaller, Nina Sarah Gowert, Oliver Borst, Florian Läng, Patrick Münzer, Dieter Willbold, Lothar Gremer, Seeger Rc and C. Patrick Reynolds. Their work appears in journals such as Thrombosis and Haemostasis, Cellular Signalling, Science Signaling, Acta Haematologica and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.